Please use this identifier to cite or link to this item:
Title: Topical Imiquimod Treatment of Lentigo Maligna
Authors: Ventura, F
Rocha, J
Fernandes, JC
Pardal, F
Brito, C
Keywords: Neoplasias da Pele
Issue Date: 2009
Publisher: Karger
Citation: Case Rep Dermatol. 2009;1(1):78-81.
Abstract: Lentigo maligna (LM) is the in situ phase of lentigo maligna melanoma, which may progress to invasive melanoma if left untreated. It mainly occurs on sun-exposed areas of elderly patients. The lesions can be large and conventional surgery can be difficult, particularly on the face. Recent reports indicate that topical imiquimod 5% cream is effective in the treatment of LM. It may be an alternative when surgery or other classical treatments are not possible in elderly patients. We describe an 80-year-old Caucasian woman with a 10-year history of a histologically verified extensive LM of the face. She was treated with imiquimod 5% cream once daily. After four months it showed complete clinical response. One year after the treatment the patient was still free from recurrence.
Peer review: yes
Appears in Collections:HB - DER - Artigos
HB - AN PAT - Artigos

Files in This Item:
File Description SizeFormat 
Topical Imiquimod Treatment of Lentigo Maligna.pdf163,17 kBAdobe PDFView/Open

FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote Degois 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.